Cargando…
Effective anesthetic management with remimazolam and ketamine without muscle relaxants for parotidectomy in a patient with myotonic dystrophy: A case report
Patients with myotonic dystrophy (DM) are highly sensitive to anesthetics, muscle relaxants, and opioids, necessitating appropriate anesthetic management. Recently, remimazolam, an ultra-short-acting benzodiazepine, has been approved for use as a general anesthetic in Japan, and patients with DM hav...
Autores principales: | Ishida, Yoshiaki, Habu, Miki (Iwasaki), Toba, Yoshie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410637/ https://www.ncbi.nlm.nih.gov/pubmed/36042643 http://dx.doi.org/10.1097/MD.0000000000030415 |
Ejemplares similares
-
Anesthetic management for a patient with myotonic dystrophy with remimazolam
por: Morimoto, Yasuhiro, et al.
Publicado: (2021) -
General anesthesia using remimazolam and remifentanil in combination with local anesthetics without neuromuscular blocking agents in a patient with myotonic dystrophy
por: Koyama, Yukihide, et al.
Publicado: (2023) -
Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy
por: Horikoshi, Yuta, et al.
Publicado: (2021) -
Myotonic Dystrophy and Anesthetic Challenges: A Case Report and Review
por: Mangla, Chanchal, et al.
Publicado: (2019) -
Anesthetic management with remimazolam for laryngectomy in a severely underweight patient with facioscapulohumeral muscular dystrophy
por: Seo, Kwon Hui, et al.
Publicado: (2023)